Article
Gilead scraps late-stage trial of blood cancer treatment
Rating:
0.0
Views:
40
Likes:
1
Library:
1
Gilead Sciences Inc said on Friday it was stopping a late-stage trial of its blood cancer combination treatment following an analysis that showed it would not be effective.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value